Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1205)
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$77.92
Total Value
$584.40K
Shares Held After
400,330
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$583.81
Total Value
$210.17K
Shares Held After
40,513
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$582.32
Total Value
$46.59K
Shares Held After
40,873
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
371
Price
$581.52
Total Value
$215.74K
Shares Held After
40,953
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,494
Price
$580.50
Total Value
$867.27K
Shares Held After
41,324
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,752
Price
$579.58
Total Value
$1.02M
Shares Held After
42,818
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$578.63
Total Value
$1.08M
Shares Held After
44,570
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,567
Price
$577.58
Total Value
$905.07K
Shares Held After
46,444
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
624
Price
$576.34
Total Value
$359.64K
Shares Held After
48,011
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,378
Price
$575.40
Total Value
$792.90K
Shares Held After
48,635
% of Holdings
2.8%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,937
Price
$66.87
Total Value
$129.53K
Shares Held After
488,437
% of Holdings
0.4%
Dyne Therapeutics, Inc. (DYN)
Kerr Douglas — Chief Medical Officer
Shares
1,564
Price
$18.36
Total Value
$28.72K
Shares Held After
170,042
% of Holdings
0.9%
Dyne Therapeutics, Inc. (DYN)
Lucera Erick — Chief Financial Officer
Shares
1,448
Price
$18.36
Total Value
$26.59K
Shares Held After
123,925
% of Holdings
1.2%
Dyne Therapeutics, Inc. (DYN)
Cox John — Director
Shares
3,311
Price
$18.36
Total Value
$60.79K
Shares Held After
370,834
% of Holdings
0.9%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
855
Price
$3.61
Total Value
$3.08K
Shares Held After
90,164
% of Holdings
0.9%
Dyne Therapeutics, Inc. (DYN)
Friedl-Naderer Johanna — Chief Commercial Officer
Shares
228
Price
$18.36
Total Value
$4.19K
Shares Held After
154,353
% of Holdings
0.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,728
Price
$3.61
Total Value
$9.84K
Shares Held After
1,043,327
% of Holdings
0.3%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
3,361
Price
$3.61
Total Value
$12.12K
Shares Held After
678,639
% of Holdings
0.5%
CEL SCI CORP (CVM)
KERSTEN GEERT R — Director
Shares
100,000
Price
$1.19
Total Value
$119.00K
Shares Held After
222,497
% of Holdings
44.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
14,056
Price
$28.58
Total Value
$401.79K
Shares Held After
63,443
% of Holdings
18.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
600
Price
$70.81
Total Value
$42.49K
Shares Held After
767,780
% of Holdings
0.1%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,950
Price
$69.79
Total Value
$275.66K
Shares Held After
768,380
% of Holdings
0.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,350
Price
$68.88
Total Value
$230.75K
Shares Held After
772,330
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,100
Price
$68.10
Total Value
$143.01K
Shares Held After
775,680
% of Holdings
0.3%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
44,679
Price
$0.54
Total Value
$24.13K
Shares Held After
1,126,496
% of Holdings
3.8%
Absci Corp (ABSI)
Pangalos Menelas N — Director
Shares
37,453
Price
$5.36
Total Value
$200.75K
Shares Held After
232,308
% of Holdings
16.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,500
Price
$67.98
Total Value
$101.97K
Shares Held After
486,500
% of Holdings
0.3%
Lantern Pharma Inc. (LTRN)
KEYSER D JEFFREY — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
94,303
% of Holdings
51.5%
Lantern Pharma Inc. (LTRN)
Schalop Lee Troy — Director
Shares
48,544
Price
$2.06
Total Value
$100.00K
Shares Held After
48,544
% of Holdings
100.0%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
6,988
Price
$450.00
Total Value
$3.14M
Shares Held After
26,088
% of Holdings
21.1%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Jerrold B — Director
Shares
12,500
Price
$8.01
Total Value
$100.12K
Shares Held After
513,884
% of Holdings
2.4%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
800
Price
$13.83
Total Value
$11.06K
Shares Held After
830,584
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$29.36
Total Value
$186.35K
Shares Held After
69,792
% of Holdings
8.3%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
16,940
Price
$3.29
Total Value
$55.73K
Shares Held After
808,008
% of Holdings
2.1%
MANNKIND CORP (MNKD)
Thomson David — EVP Genl Counsel & Secretary
Shares
3,033
Price
$3.29
Total Value
$9.98K
Shares Held After
826,299
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
2,800
Price
$73.12
Total Value
$204.74K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,900
Price
$72.15
Total Value
$425.67K
Shares Held After
770,580
% of Holdings
0.8%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,802
Price
$71.37
Total Value
$699.57K
Shares Held After
776,480
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
1,398
Price
$70.29
Total Value
$98.26K
Shares Held After
786,282
% of Holdings
0.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
100
Price
$67.85
Total Value
$6.78K
Shares Held After
787,680
% of Holdings
0.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
73,296
Price
$6.20
Total Value
$454.44K
Shares Held After
103,417
% of Holdings
41.5%
X4 Pharmaceuticals, Inc (XFOR)
KIRSKE DAVID — Chief Financial Officer
Shares
16,961
Price
$4.29
Total Value
$72.82K
Shares Held After
176,293
% of Holdings
8.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
3,322
Price
$26.71
Total Value
$88.73K
Shares Held After
466,375
% of Holdings
0.7%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
4,281
Price
$37.09
Total Value
$158.77K
Shares Held After
216,744
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
14,219
Price
$36.64
Total Value
$520.98K
Shares Held After
221,025
% of Holdings
6.0%
UNITED THERAPEUTICS Corp (UTHR)
Mesa Nilda — Director
Shares
258
Price
$581.93
Total Value
$150.14K
Shares Held After
5,028
% of Holdings
4.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
56
Price
$583.44
Total Value
$32.67K
Shares Held After
40,513
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,464
Price
$582.80
Total Value
$853.22K
Shares Held After
40,569
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
982
Price
$581.62
Total Value
$571.15K
Shares Held After
42,033
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,706
Price
$580.62
Total Value
$990.53K
Shares Held After
43,015
% of Holdings
3.8%
Showing 1–50 of 1205 transactions (page 1 of 25)